Company Information

  

Address: 2 HAMA?AYAN STREET
MODI?IN TECHNOLOGY PARK 
City: MODI?IN 
State:  
Zip Code: 7177871 
Telephone: 972-2-548-9100 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

Our legal and commercial name is BioLineRx Ltd. We are a company limited by shares organized under the laws of the State of Israel. Our principal executive offices are located at 2 HaMa'ayan Street, Modi'in 7177871, Israel, and our telephone number is +972 (8) 642-9100. We were founded in 2003 by leading institutions in the Israeli life sciences industry, including Teva Pharmaceutical Industries Ltd., or Teva. We completed our initial public offering in Israel in February 2007 and our ordinary shares are traded on the TASE under the symbol "BLRX." In July 2011, we listed our ADSs on Nasdaq and they are traded under the symbol "BLRX." Our capital expenditures for the years ended December 31, 2014 and 2015 were $0.2 million and $2.7 million, respectively. The amount for 2015 includes the leasehold improvements on our new facility in Modi'in, as well as the purchase of laboratory equipment. For the year ended December 31, 2016, our capital expenditures were immaterial.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
12/2016-0.28NAN/E
09/2016-0.28NAN/E
03/2016-0.32NAN/E
09/2015-1.21NAN/E
12/2012-1.20NAN/E
12/2011-1.10NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity-0.08Total Liab/Total Assets0.10
Net Inc/Total Assets-0.41Total Liab/Inv Cap0.11
Net Inc/Inv Cap-0.45Total Liab/Comm Equity0.02
Pretax Inc/Net SalesNAInterest Coverage Ratio-719.05
Net Inc/Net SalesNACurr Debt/Equity0.00
Cash Flow/Net SalesNALTD/Equity0.01
SG&A/NetSalesNATotal Debt/Equity0.01
Asset Utilization   Liquidity  
Net Receivables TurnoverNAQuick Ratio9.86
Inventory TurnoverNACurrent Ratio9.86
Inventory Day SalesNANet Rec/Curr Assets0.01
Net Sales/Work CapNAInv/Curr AssetsNA
Net Sales/PP&ENA  

Income Statement (Millions)

  12/31/2016 12/31/2015 12/31/2014 12/31/2013
Total Revenues(Net Sales) NA NA NA NA
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 5.34 4.71 5.39 4.80
Operating Income -16.51 -16.20 -17.26 -17.01
Interest Exp 0.02 0.11 0.45 1.90
Pretax Income -15.84 -14.40 -11.08 -17.02
Other Income 0.69 1.90 6.63 1.88
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -15.84 -14.40 -11.08 -17.02

Balance Sheet (Millions)

Assets 12/31/2016 12/31/2015 12/31/2014 12/31/2013
Cash & Short Term Investments 35.62 47.66 34.68 18.22
Receivables - Total 0.22 0.29 0.26 0.36
Inventories - Total NA NA NA NA
Total Current Assets 36.10 48.18 35.16 18.84
Net Property, Plant & Equipment 2.61 2.91 0.72 0.71
Total Assets 38.94 51.30 36.21 20.02
Liabilities        
Accounts Payable 2.59 1.91 1.65 2.29
Debt in Current Liabilities 0.09 0.09 0.00 0.00
Total Current Liabilities 3.66 3.14 2.91 3.05
Long-Term Debt 0.25 0.34 0.00 0.00
Total Liabilities 3.91 3.69 4.41 8.29
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 1.51 1.46 1.06 0.64
Retained Earnings -175.21 -159.37 -144.97 -133.89
Treasury Stock NA NA NA NA
Total Stockholders' Equity 35.03 47.61 31.81 11.72
Total Liabilities and Stockholders' Equity 38.94 51.30 36.21 20.02

Cash Flow Summary (Millions)

Categories 12/31/2016 12/31/2015 12/31/2014 12/31/2013
Net Cash Provided by Operating Activities -14.51 -14.17 -15.75 -19.53
Net Cash Provided by Investing Activities 9.30 -15.60 -19.73 -5.32
Net Cash Provided by Financing Activities 2.09 29.49 32.64 15.07

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20120.00-20.44-1.20
12/20130.00-17.02--
12/20140.00-11.08--
12/20150.00-14.40--
12/20160.00-15.84-0.28
Growth RatesNaN----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/173438,74037.03




Report Date : 12/11/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.